The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lillard, J. W.
Right arrow Articles by McGhee, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lillard, J. W., Jr.
Right arrow Articles by McGhee, J. R.
The Journal of Immunology, 1999, 162: 1959-1965.
Copyright © 1999 by The American Association of Immunologists

Lymphotactin Acts as an Innate Mucosal Adjuvant1

James W. Lillard, Jr.*, Prosper N. Boyaka*, Joseph A. Hedrick{dagger}, Albert Zlotnik{ddagger} and Jerry R. McGhee2,*

* Department of Microbiology and Immunobiology Vaccine Center, University of Alabama, Birmingham, AL 35294; {dagger} Schering-Plough Research Institute, Kenilworth, NJ 07033; and {ddagger} DNAX Research Institute of Cellular and Molecular Biology, Palo Alto, CA 93404

Lymphotactin (Lptn) is a C chemokine produced predominantly by NK and CD8-positive (CD8+) T cells including {gamma}{delta} TCR-positive (TCR+) intraepithelial lymphocytes. Lptn is chemotactic for NK and T cells and likely plays an important role in maintaining the integrity of the epithelium and in mucosal immune responses. In this study, we characterized the immune responses to OVA given intranasally with Lptn to mice. This regimen enhanced OVA-specific serum Ab responses and Ab titers in mucosal secretions. Lptn also enhanced OVA-specific Ab-forming cells in mucosal and systemic compartments. CD4-positive (CD4+) T cells isolated from mucosal compartments and spleens of mice intranasally immunized with OVA plus Lptn displayed higher OVA-specific proliferative responses and greater synthesis of IFN-{gamma}, IL-2, IL-4, IL-5, IL-6, and IL-10 than did CD4+ T cells from mice given OVA without Lptn. These studies indicate that Lptn has adjuvant properties and suggest that Lptn present in the mucosa has the potential to enhance mucosal and systemic Ab responses through help provided by Th1- and Th2-type cells to link the initial innate signals of the mucosa with the acquired immune system.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
U. P. Singh, S. Singh, R. Singh, R. K. Karls, F. D. Quinn, M. E. Potter, and J. W. Lillard Jr.
Influence of Mycobacterium avium subsp. paratuberculosis on Colitis Development and Specific Immune Responses during Disease
Infect. Immun., August 1, 2007; 75(8): 3722 - 3728.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Miao, B. A. Premack, Z. Wei, Y. Wang, C. Gerard, H. Showell, M. Howard, T. J. Schall, and R. Berahovich
Proinflammatory Proteases Liberate a Discrete High-Affinity Functional FPRL1 (CCR12) Ligand from CCL23
J. Immunol., June 1, 2007; 178(11): 7395 - 7404.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Meddows-Taylor, S. L. Donninger, M. Paximadis, D. B. Schramm, F. S. Anthony, G. E. Gray, L. Kuhn, and C. T. Tiemessen
Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission
J. Gen. Virol., July 1, 2006; 87(7): 2055 - 2065.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Palaniappan, S. Singh, U. P. Singh, R. Singh, E. W. Ades, D. E. Briles, S. K. Hollingshead, W. Royal III, J. S. Sampson, J. K. Stiles, et al.
CCL5 Modulates Pneumococcal Immunity and Carriage
J. Immunol., February 15, 2006; 176(4): 2346 - 2356.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Kobayashi, T. Kohda, K. Kataoka, H. Ihara, S. Kozaki, D. W. Pascual, H. F. Staats, H. Kiyono, J. R. McGhee, and K. Fujihashi
A Novel Neurotoxoid Vaccine Prevents Mucosal Botulism
J. Immunol., February 15, 2005; 174(4): 2190 - 2195.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. Palaniappan, S. Singh, U. P. Singh, S. K. K. Sakthivel, E. W. Ades, D. E. Briles, S. K. Hollingshead, J. C. Paton, J. S. Sampson, and J. W. Lillard Jr.
Differential PsaA-, PspA-, PspC-, and PdB-Specific Immune Responses in a Mouse Model of Pneumococcal Carriage
Infect. Immun., February 1, 2005; 73(2): 1006 - 1013.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
U. P. Singh, S. Singh, P. N. Boyaka, J. R. McGhee, and J. W. Lillard Jr
Granulocyte chemotactic protein-2 mediates adaptive immunity in part through IL-8R{beta} interactions
J. Leukoc. Biol., December 1, 2004; 76(6): 1240 - 1247.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. P. Singh, S. Singh, P. Ravichandran, D. D. Taub, and J. W. Lillard Jr.
Viral Macrophage-Inflammatory Protein-II: A Viral Chemokine That Differentially Affects Adaptive Mucosal Immunity Compared with Its Mammalian Counterparts
J. Immunol., November 1, 2004; 173(9): 5509 - 5516.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Kataoka, J. R. McGhee, R. Kobayashi, K. Fujihashi, S. Shizukuishi, and K. Fujihashi
Nasal Flt3 Ligand cDNA Elicits CD11c+CD8+ Dendritic Cells for Enhanced Mucosal Immunity
J. Immunol., March 15, 2004; 172(6): 3612 - 3619.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. Muller, S. Bischof, F. Sommer, M. Lohoff, W. Solbach, and T. Laskay
Differential Production of Macrophage Inflammatory Protein 1{gamma} (MIP-1{gamma}), Lymphotactin, and MIP-2 by CD4+ Th Subsets Polarized In Vitro and In Vivo
Infect. Immun., November 1, 2003; 71(11): 6178 - 6183.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Stievano, V. Tosello, N. Marcato, A. Rosato, A. Sebelin, L. Chieco-Bianchi, and A. Amadori
CD8+{alpha}{beta}+ T Cells That Lack Surface CD5 Antigen Expression Are a Major Lymphotactin (XCL1) Source in Peripheral Blood Lymphocytes
J. Immunol., November 1, 2003; 171(9): 4528 - 4538.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. P. Singh, S. Singh, D. D. Taub, and J. W. Lillard Jr.
Inhibition of IFN-{gamma}-Inducible Protein-10 Abrogates Colitis in IL-10-/- Mice
J. Immunol., August 1, 2003; 171(3): 1401 - 1406.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. N. Boyaka, A. Tafaro, R. Fischer, S. H. Leppla, K. Fujihashi, and J. R. McGhee
Effective Mucosal Immunity to Anthrax: Neutralizing Antibodies and Th Cell Responses Following Nasal Immunization with Protective Antigen
J. Immunol., June 1, 2003; 170(11): 5636 - 5643.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. W. Lillard Jr, U. P. Singh, P. N. Boyaka, S. Singh, D. D. Taub, and J. R. McGhee
MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity
Blood, February 1, 2003; 101(3): 807 - 814.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. N. Boyaka, M. Ohmura, K. Fujihashi, T. Koga, M. Yamamoto, M.-N. Kweon, Y. Takeda, R. J. Jackson, H. Kiyono, Y. Yuki, et al.
Chimeras of Labile Toxin One and Cholera Toxin Retain Mucosal Adjuvanticity and Direct Th Cell Subsets Via Their B Subunit
J. Immunol., January 1, 2003; 170(1): 454 - 462.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Huang, F. Li, J. R. Gordon, and J. Xiang
Synergistic Enhancement of Antitumor Immunity with Adoptively Transferred Tumor-specific CD4+ and CD8+ T Cells and Intratumoral Lymphotactin Transgene Expression
Cancer Res., April 1, 2002; 62(7): 2043 - 2051.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
U. F. Power, T. Huss, V. Michaud, H. Plotnicky-Gilquin, J.-Y. Bonnefoy, and T. N. Nguyen
Differential Histopathology and Chemokine Gene Expression in Lung Tissues following Respiratory Syncytial Virus (RSV) Challenge of Formalin-Inactivated RSV- or BBG2Na-Immunized Mice
J. Virol., December 15, 2001; 75(24): 12421 - 12430.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. F. Staats, C. P. Bradney, W. M. Gwinn, S. S. Jackson, G. D. Sempowski, H.-X. Liao, N. L. Letvin, and B. F. Haynes
Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization
J. Immunol., November 1, 2001; 167(9): 5386 - 5394.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. W. Lillard Jr., P. N. Boyaka, D. D. Taub, and J. R. McGhee
RANTES Potentiates Antigen-Specific Mucosal Immune Responses
J. Immunol., January 1, 2001; 166(1): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Cerdan, E. Serfling, and D. Olive
The C-class chemokine, lymphotactin, impairs the induction of Th1-type lymphokines in human CD4+ T cells
Blood, July 15, 2000; 96(2): 420 - 428.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.